U-M Center for Circulatory Support provides leadership in research and innovation of the devices that help patients survive the wait for a heart transplant ANN ARBOR, Mich., June

TUCSON, Ariz., May 24, 2012 /PRNewswire/ -- SynCardia Systems, Inc.

FRAMINGHAM, Mass. and SYDNEY, May 23, 2012 /PRNewswire/ -- HeartWare International, Inc.

Statins prevent cancer and reduce death from all causes in heart transplant recipients.

Cancer is the leading cause of death late after heart transplantation. Now, new research shows that statins, immunomondulatory drugs, may benefit patients beyond their lipid lowering effects.